# Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16

> **NCT06410131** · PHASE1 · RECRUITING · sponsor: **Sound Biopharmaceuticals Ltd.** · enrollment: 68 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** FTL008.16

## Key facts

- **NCT ID:** NCT06410131
- **Lead sponsor:** Sound Biopharmaceuticals Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-27
- **Primary completion:** 2026-11
- **Final completion:** 2027-11
- **Target enrollment:** 68 (ESTIMATED)
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06410131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06410131, "Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT06410131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*